We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
A malleable catalyst dominates the metabolism of drugs
Summary
Researchers investigated micro- and nano-plastics as emerging global pollutants, noting a critical knowledge gap in nanoplastics research due to insufficient analytical methods, and highlighting that nanoplastics pose greater toxicity concerns than microplastics because of their ability to penetrate biological systems more readily.
Micro-nano plastics originating from the prevalent usage of plastics have raised increasingly alarming concerns worldwide. However, there remains a fundamental knowledge gap in nanoplastics because of the lack of effective analytical ...Plastics are now omnipresent in our daily lives. The existence of microplastics (1 µm to 5 mm in length) and possibly even nanoplastics (<1 μm) has recently raised health concerns. In particular, nanoplastics are believed to be more toxic since their ...
Sign in to start a discussion.
More Papers Like This
Micro (nano) plastics in wastewater: A critical review on toxicity risk assessment, behaviour, environmental impact and challenges
Researchers reviewed the sources, detection methods, toxicity, environmental fate, and wastewater treatment options for micro- and nanoplastics, finding that nanoplastics are especially persistent and toxic due to their large surface area and ability to carry co-pollutants, and identifying key research gaps in quantification, degradation mechanisms, and sensor development.
Micro(nano)plastics as a vector of pharmaceuticals in aquatic ecosystem: Historical review and future trends
This systematic review examines how microplastics and nanoplastics in water can absorb and carry pharmaceutical drugs, creating a combined pollution threat. When medications attach to tiny plastic particles in rivers and oceans, they may become more harmful to aquatic life and potentially to humans who consume contaminated seafood or water. The research traces how this emerging double-threat has grown since 2018 and identifies key knowledge gaps.
Microplastics and Nanoplastics as Emerging Modifiers of Human Drug Pharmacokinetics: Implications for Adme and Therapeutic Outcomes
**TLDR:** This review of existing research found that tiny plastic particles we're exposed to from the environment might interfere with how medications work in our bodies. These microplastics and nanoplastics can potentially make some drugs less effective or change how they're absorbed, which could be especially risky for critical medications like blood thinners and seizure drugs. While scientists need more human studies to fully understand the impact, this suggests our plastic pollution problem might also be affecting how well our medicines work.
A critical viewpoint on current issues, limitations, and future research needs on micro- and nanoplastic studies: From the detection to the toxicological assessment.
This critical review examines the current methods for detecting and characterizing micro- and nanoplastics in various environmental samples, as well as reported toxic effects from in vivo and in vitro studies. The authors found that while substantial effort has been made to understand microplastic behavior, the scientific community is still far from a complete understanding of how these particles behave in biological systems. The review calls for improved standardized protocols and more studies focused on uptake kinetics, accumulation, and biodistribution.
Micro‐ and Nano‐Plastic Pollution
Researchers review the growing global threat of micro- and nanoplastics — plastic particles ranging from 0.1mm down to 100 nanometers — exploring how they bind to toxic chemicals as they travel through the environment and how emerging photocatalytic technologies using sunlight could offer sustainable new ways to break them down.